| C-11 Kristin Karlsson Regulatory pharmacometrics in the EU in practice and the role of the Modelling and Simulation Working Group Thursday 13:45-14:15 |
| C-12 Anna Nordmark The new draft EMA Guidance on PBPK – The qualification of the intended use concept Thursday 14:15-14:45 |
| D-03 Miro Eigenmann Therapeutic antibody concentrations at the biophase Friday 09:40-10:00 |
| D-08 Salvatore D'Agate Model-based screening of compounds for the treatment of Chagas disease, a neglected tropical disease. Friday 11:35-11:55 |
